The heart pump device market size is expected to reach USD 11,297.43 million by 2034, according to a new study by Polaris Market Research. The report “Heart Pump Device Market Size, Share, & Trends, Analysis Report: By Type (Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices), By Product, By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
A heart pump device is a mechanical device that helps the heart circulate blood when it is too weak to function properly. Doctors and patients prefer treatments that require smaller incisions, shorter hospital stays, and quicker recovery times. Many new heart pump devices can be inserted with minimally invasive techniques, such as through blood vessels instead of open-heart surgery. This makes them suitable for patients who are too weak for major surgical procedures. As hospitals shift toward less invasive procedures to reduce costs and improve outcomes, heart pumps that support this trend are seeing increased adoption, making this a strong market driver.
Heart pumps are no longer used only in long-term heart failure. They are now being used in emergency settings, such as during heart attacks or cardiac shock, to stabilize patients quickly. Devices such as Impella and ECMO systems help maintain blood flow in critical situations. Hospitals are increasingly adding these technologies to their emergency and intensive care units. This expansion into short-term and acute care use broadens the market significantly, as it adds a new group of patients who can benefit from heart pump support.
Heart Pump Device Market Report Highlights
By type, in 2024, the implanted heart pump devices segment dominated the market due to their long-term use in patients affected by advanced heart failure.
The cardiac center segment, by end use, is expected to witness significant growth during the forecast period. Cardiac centers play a significant role in follow-up care and specialized treatment.
In 2024, the North America heart pump device market dominated with the largest share due to its advanced healthcare infrastructure; high healthcare spending; and strong presence of key players like Abbott, ABIOMED, and Medtronic.
The Asia Pacific heart pump device market is experiencing significant growth due to improving healthcare systems, rising heart disease rates, and increasing investments in medical technologies.
A few global key market players are Abbott; ABIOMED; Berlin Heart; BiVACOR Inc.; Getinge; Jarvik Heart, Inc.; Leviticus Cardio; LivaNova PLC; Picard Medical, Inc.; and Teleflex Incorporated.
Polaris Market Research has segmented the heart pump device market report on the basis of type, product, end use, and region:
By Type (Revenue – USD Million, 2020–2034)
Implanted Heart Pump Devices
Extracorporeal Heart Pump Devices
By Product (Revenue – USD Million, 2020–2034)
Ventricular Assist Devices (VADs)
Left Ventricular Assist Devices (LVADs)
Right Ventricular Assist Devices (RVADs)
BiVAD Ventricular Assist Devices (BiVADs)
Percutaneous Ventricular Assist Devices (PVADs)
Intra-Aortic Balloon Pumps (IABPs)
Extracorporeal Membrane Oxygenation (ECMO)
By End Use (Revenue – USD Million, 2020–2034)
Hospitals
Cardiac Centers
Research Institute
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook